Valuation: Globus Medical, Inc.

Market Cap 9.27B 8.46B 7.82B 7.06B 13.29B 866B 13.81B 94.42B 37.33B 468B 34.78B 34.05B 1,477B P/E 2026 *
16.9x
P/E 2027 * 15.2x
Enterprise Value 8.45B 7.71B 7.12B 6.43B 12.11B 790B 12.59B 86.05B 34.01B 426B 31.7B 31.03B 1,346B EV / Sales 2026 *
2.72x
EV / Sales 2027 * 2.46x
Free-Float
82.03%
Yield 2026 *
-
Yield 2027 * -
1 day+0.77%
1 week-6.45%
Current month-9.63%
1 month-8.06%
3 months-18.41%
6 months-10.64%
Current year-19.22%
1 week 69.02
Extreme 69.02
73.45
1 month 69.02
Extreme 69.02
88.1
Current year 69.02
Extreme 69.02
101.4
1 year 69.02
Extreme 69.02
101.4
3 years 44.02
Extreme 44.02
101.4
5 years 43.38
Extreme 43.385
101.4
10 years 20.81
Extreme 20.81
101.4
Manager TitleAgeSince
Chief Executive Officer 47 2025-07-17
Director of Finance/CFO 41 2025-07-17
Investor Relations Contact - -
Director TitleAgeSince
Chairman 59 2002-12-31
Director/Board Member 60 2002-12-31
Director/Board Member 72 2011-04-20
Date Insider Type Main position Quantity % Market Cap. Importance
11/4/26 Sell

Director

-5,000 0.0044%
9/15/26 Exercice

Director

90,000 0.0805%
8/18/26 Exercice

Director

75,000 0.0662%
Change 5-day change 1-year change 3-year change Capi.($)
+0.77%-6.45%-15.45%+54.77% 9.27B
-0.22%-4.40%-19.63%+4.95% 181B
-1.56%-0.88%-0.08%+34.72% 125B
+0.19%-0.20%-11.51%+10.32% 121B
+1.12%-0.96%-41.94%+0.79% 90.52B
-0.64%-0.45%-3.69%+78.62% 66.9B
+0.31%+0.73%+12.35%-7.37% 58.68B
+1.19%-0.59%+4.22%+50.63% 54.38B
+0.86%-1.59%+1.78%+38.65% 48.46B
+0.84%+4.77%+3.97%-0.26% 35.4B
Average +0.43%-1.29%-7.00%+26.58% 79B
Weighted average by Cap. +0.24%-1.59%-10.07%+20.88%

Financials

2026 *2027 *
Net sales 3.11B 2.83B 2.62B 2.37B 4.45B 290B 4.63B 31.65B 12.51B 157B 11.66B 11.42B 495B 3.28B 2.99B 2.77B 2.5B 4.7B 307B 4.89B 33.41B 13.21B 165B 12.31B 12.05B 522B
Net income 567M 517M 478M 431M 812M 52.95B 844M 5.77B 2.28B 28.58B 2.13B 2.08B 90.25B 626M 571M 528M 476M 897M 58.5B 933M 6.38B 2.52B 31.58B 2.35B 2.3B 99.71B
Net Debt -822M -750M -693M -626M -1.18B -76.85B -1.23B -8.38B -3.31B -41.48B -3.09B -3.02B -131B -1.2B -1.09B -1.01B -910M -1.71B -112B -1.78B -12.18B -4.82B -60.34B -4.49B -4.39B -191B
Projected Income Statement - Annual - Globus Medical, Inc.
Logo Globus Medical, Inc.
Globus Medical, Inc. is a global musculoskeletal company. The Company provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The Company offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. Its segments include Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities. The Company also provides digital healthcare solutions.
Employees
6,000
Date Price Change Volume
26-11-18 US$70.53 +0.77% 1,427,322
26-11-17 US$69.99 -0.72% 1,140,847
26-11-16 US$70.50 -2.27% 1,375,325
26-11-13 US$72.14 -0.22% 1,549,142
26-11-12 US$72.30 -4.10% 1,694,661
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - Globus Medical, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
70.53USD
Average target price
93.43USD
Spread / Average Target
+32.47%
  1. Stock Market
  2. Stocks
  3. GMED Stock